Dermatology
Latest News
Roflumilast cream appears safe, effective for children with psoriasis, researchers report
In children aged 2-11 years, roflumilast cream 0.3% was well tolerated and improved signs and symptoms of psoriasis, researchers report.
Article
Necessary Updates to Skin Cancer Risk Stratification
News
Does colchicine have a role in treating excess ASCVD risk in patients with chronic inflammatory conditions?
Experts in rheumatology, dermatology, and gastroenterology assess the potential of colchicine 0.5 mg to treat residual risk for atherosclerotic...
Latest News
Study points to need to improve identification of culprit in SJS/TEN cases
A single culprit drug was labeled in 17 cases, but physicians communicated certainty in only 7 of those cases.
Latest News
Imaging techniques will revolutionize cancer detection, expert predicts
Jennifer Barton, PhD, and her colleagues are developing an OCT/fluorescence imaging falloposcope that is 0.8 mm in diameter, flexible, and...
News
FDA approves ritlecitinib for ages 12 and up for alopecia areata
It is the second JAK inhibitor approved for treating alopecia areata, following approval of baricitinib (Olumiant) in June 2022 for alopecia...
Latest News
Study supports new NCCN classification for cutaneous squamous cell carcinoma
The high- and very-high-risk groups in the NCCN guidelines identify SCCs at greatest risk for developing poor outcomes.
Latest News
Warts difficult to eradicate in immunocompromised children
Warts completely resolved with treatment in only 24% of children undergoing active cancer treatment.
Latest News
Prognostic factors of SCCs in organ transplant recipients worse compared with general population
SCCs developed most frequently on the head/neck in organ transplant recipients and on the arms/hands in the general population.
News
FDA warns of tattoo ink tied to dangerous infections
“I’ve seen several different infections from tattooing, and they are from organisms that tend to contaminate things in damp, liquid-type...